SLGL
Sol-Gel Technologies Ltd.
There isn't enough reported data to score SLGL yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SLGL Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Stable | |
| Strong |
SLGL's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SLGL PE Valuation
SLGL has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SLGL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect SLGL's losses to grow, with revenue declining.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SLGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.64 | -$4.38 |
| Q4 2023 | -$10.10 | -$3.64 |
| Q3 2023 | -$10.90 | -765% |
| Q2 2023 | -$10.30 | -379% |
| Q1 2023 | -$8.16 | -3500% |
| Q4 2022 | -$6.46 | -869% |
| Q3 2022 | $1.64 | +$9.20 |
| Q2 2022 | $3.69 | +$15.49 |
SLGL is still losing money, but far less than before: $5.64 per share over the past year, against $15.60 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SLGL on earnings quality, reporting a profit while its opponent remains loss making.
SLGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $591K | -97% |
| Q1 2026 | $108K | -90% |
| Q4 2025 | $696K | +150% |
| Q3 2025 | $400K | -93% |
| Q2 2025 | $17.3M | +218% |
| Q1 2025 | $1M | +121% |
| Q4 2024 | $278K | -38% |
| Q3 2024 | $5.4M | +2417% |
SLGL's revenue has slid since its 2021 peak: $591,000 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -704% | -769 points |
| Q1 2026 | -3569% | -2690 points |
| Q4 2025 | -490% | +1704 points |
| Q3 2025 | -1572% | -1557 points |
| Q2 2025 | 65% | +35 points |
| Q1 2025 | -880% | -2320 points |
| Q4 2024 | -2194% | -984 points |
| Q3 2024 | -15% | +2946 points |
SLGL's operating margin was −704% last quarter, down 769 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over SLGL on profitability, with a higher operating margin.
SLGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2024 | $0 | $0 |
| Q1 2024 | $0 | $0 |
| Q4 2023 | $0 | $0 |
| Q3 2023 | $0 | $0 |
| Q2 2023 | $0 | $0 |
| Q1 2023 | $0 | $0 |
| Q4 2022 | $0 | +$15.8M |
| Q3 2022 | $0 | $0 |
SLGL has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
SLGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +434K shares |
| 1 year | +17% | +485K shares |
| 3 years | +41% | +958K shares |
| 5 years | +42% | +970K shares |
| Available history | +65% | +1.3M shares |
SLGL has 3M diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over SLGL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
SLGL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -10.4x | Net Cash |
| Q3 2024 | -4.8x | Net Cash |
| Q3 2022 | -1.6x | Net Cash |
| Q2 2022 | -0.5x | Net Cash |
| Q1 2022 | -9.2x | Net Cash |
| Q4 2021 | -4.8x | Net Cash |
SLGL has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SLGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 15.5 | Oversold |
SLGL's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SLGL PE vs Healthcare Sector
| Metric | SLGL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SLGL has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SLGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.2 | 15% below |
| 20 week MA | $72.0 | 22% below |
| 50 week MA | $69.9 | 20% below |
| 100 week MA | $42.6 | 32% above |
| 200 week MA | $30.7 | 83% above |
SLGL has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 83% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SLGL on trend strength, trading above more of its moving averages.
SLGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $92.3 | $95.0 | +2.9% |
| 2021 | $95.0 | $67.4 | -29% |
| 2022 | $67.4 | $45.0 | -33% |
| 2023 | $45.0 | $11.1 | -75% |
| 2024 | $11.1 | $11.2 | +0.9% |
| 2025 | $11.2 | $41.9 | +274% |
| 2026 YTD | $41.9 | $56.3 | +34% |
SLGL has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.